493 related articles for article (PubMed ID: 34742369)
21. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.
Global Burden of Disease 2021 Health Financing Collaborator Network
Lancet Glob Health; 2023 Mar; 11(3):e385-e413. PubMed ID: 36706770
[TBL] [Abstract][Full Text] [Related]
22. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
[TBL] [Abstract][Full Text] [Related]
23. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Universal Health Coverage Collaborators
Lancet; 2020 Oct; 396(10258):1250-1284. PubMed ID: 32861314
[TBL] [Abstract][Full Text] [Related]
24. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
25. Public and private donor financing for health in developing countries.
Howard LM
Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
[TBL] [Abstract][Full Text] [Related]
26. An analysis of government immunization program expenditures in lower and lower middle income countries 2006-12.
Nader AA; de Quadros C; Politi C; McQuestion M
Health Policy Plan; 2015 Apr; 30(3):281-8. PubMed ID: 24561878
[TBL] [Abstract][Full Text] [Related]
27. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.
Wolfson LJ; Gasse F; Lee-Martin SP; Lydon P; Magan A; Tibouti A; Johns B; Hutubessy R; Salama P; Okwo-Bele JM
Bull World Health Organ; 2008 Jan; 86(1):27-39. PubMed ID: 18235887
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE
Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329
[TBL] [Abstract][Full Text] [Related]
29. Public financing of health in developing countries: a cross-national systematic analysis.
Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
[TBL] [Abstract][Full Text] [Related]
30. National legislation and spending on vaccines in Latin America and the Caribbean.
McQuestion M; Garcia AGF; Janusz C; Andrus JK
J Public Health Policy; 2017 Feb; 38(1):3-15. PubMed ID: 28275252
[TBL] [Abstract][Full Text] [Related]
31. Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment.
Lu C; Michaud CM; Gakidou E; Khan K; Murray CJ
Lancet; 2006 Sep; 368(9541):1088-95. PubMed ID: 16997663
[TBL] [Abstract][Full Text] [Related]
32. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
33. Health spending and vaccination coverage in low-income countries.
Castillo-Zunino F; Keskinocak P; Nazzal D; Freeman MC
BMJ Glob Health; 2021 May; 6(5):. PubMed ID: 33958392
[TBL] [Abstract][Full Text] [Related]
34. Trends in vaccine investment in middle income countries.
Onishchenko K; Hill S; Wasserman M; Jones C; Moffatt M; Ruff L; Pugh SJ
Hum Vaccin Immunother; 2019; 15(10):2378-2385. PubMed ID: 30843757
[TBL] [Abstract][Full Text] [Related]
35. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
36. Development assistance for health: past trends, associations, and the future of international financial flows for health.
Dieleman JL; Schneider MT; Haakenstad A; Singh L; Sadat N; Birger M; Reynolds A; Templin T; Hamavid H; Chapin A; Murray CJ
Lancet; 2016 Jun; 387(10037):2536-44. PubMed ID: 27086170
[TBL] [Abstract][Full Text] [Related]
37. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
[TBL] [Abstract][Full Text] [Related]
38. Forecasted trends in vaccination coverage and correlations with socioeconomic factors: a global time-series analysis over 30 years.
de Figueiredo A; Johnston IG; Smith DM; Agarwal S; Larson HJ; Jones NS
Lancet Glob Health; 2016 Oct; 4(10):e726-35. PubMed ID: 27569362
[TBL] [Abstract][Full Text] [Related]
39. EPIC Studies: Governments Finance, On Average, More Than 50 Percent Of Immunization Expenses, 2010-11.
Brenzel L; Schütte C; Goguadze K; Valdez W; Le Gargasson JB; Guthrie T
Health Aff (Millwood); 2016 Feb; 35(2):259-65. PubMed ID: 26858378
[TBL] [Abstract][Full Text] [Related]
40. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.
Saxenian H; Hecht R; Kaddar M; Schmitt S; Ryckman T; Cornejo S
Health Policy Plan; 2015 Mar; 30(2):197-205. PubMed ID: 24510369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
